[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE69636814D1 - Verwendung des menschlichen choriongonadotropins in der behandlung von kaposi's-sarcoma - Google Patents

Verwendung des menschlichen choriongonadotropins in der behandlung von kaposi's-sarcoma

Info

Publication number
DE69636814D1
DE69636814D1 DE69636814T DE69636814T DE69636814D1 DE 69636814 D1 DE69636814 D1 DE 69636814D1 DE 69636814 T DE69636814 T DE 69636814T DE 69636814 T DE69636814 T DE 69636814T DE 69636814 D1 DE69636814 D1 DE 69636814D1
Authority
DE
Germany
Prior art keywords
kaposi
sarcoma
treatment
hcg
human chorion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69636814T
Other languages
English (en)
Other versions
DE69636814T2 (de
Inventor
Siegfried Schwarz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Serono SA
Original Assignee
Applied Research Systems ARS Holding NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT95RM000686A external-priority patent/ITRM950686A1/it
Priority claimed from IT96RM000309A external-priority patent/ITRM960309A1/it
Application filed by Applied Research Systems ARS Holding NV filed Critical Applied Research Systems ARS Holding NV
Publication of DE69636814D1 publication Critical patent/DE69636814D1/de
Application granted granted Critical
Publication of DE69636814T2 publication Critical patent/DE69636814T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69636814T 1995-10-16 1996-10-11 Verwendung des menschlichen choriongonadotropins in der behandlung von kaposi's-sarcoma Expired - Fee Related DE69636814T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
ITRM950686 1995-10-16
IT95RM000686A ITRM950686A1 (it) 1995-10-16 1995-10-16 Hcg nel sarcoma di kaposi
IT96RM000309A ITRM960309A1 (it) 1996-05-07 1996-05-07 Hcg nel sarcoma di kaposi
ITRM960309 1996-05-07
PCT/EP1996/004415 WO1997014428A1 (en) 1995-10-16 1996-10-11 Use of human chorionic gonadotropin in the treatment of kaposi's sarcoma

Publications (2)

Publication Number Publication Date
DE69636814D1 true DE69636814D1 (de) 2007-02-15
DE69636814T2 DE69636814T2 (de) 2007-10-04

Family

ID=26332089

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69636814T Expired - Fee Related DE69636814T2 (de) 1995-10-16 1996-10-11 Verwendung des menschlichen choriongonadotropins in der behandlung von kaposi's-sarcoma

Country Status (10)

Country Link
US (1) US6251402B1 (de)
EP (1) EP0865295B1 (de)
AT (1) ATE350052T1 (de)
AU (1) AU723646B2 (de)
CA (1) CA2243948C (de)
DE (1) DE69636814T2 (de)
DK (1) DK0865295T3 (de)
ES (1) ES2277348T3 (de)
PT (1) PT865295E (de)
WO (1) WO1997014428A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6319504B1 (en) * 1996-06-24 2001-11-20 University Of Maryland Biotechnology Institute Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin
US5997871A (en) * 1996-06-24 1999-12-07 University Of Maryland Biotechnology Insitute Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin
IT1284876B1 (it) 1996-08-07 1998-05-22 Applied Research Systems Hcg come inibitore della collagenasi
AU8526198A (en) * 1997-08-01 1999-02-22 Universite De Montreal Compounds with anti-ks and anti-hiv activity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9010058D0 (en) * 1990-05-04 1990-06-27 Health Lab Service Board Method and composition for the treatment of cancer
US5677275A (en) * 1994-08-05 1997-10-14 The United States Of America As Represented By The Department Of Health And Human Services Treatment of cancer with human chorionic gonadotropin

Also Published As

Publication number Publication date
US6251402B1 (en) 2001-06-26
ATE350052T1 (de) 2007-01-15
DK0865295T3 (da) 2007-03-19
PT865295E (pt) 2007-02-28
WO1997014428A1 (en) 1997-04-24
AU723646B2 (en) 2000-08-31
ES2277348T3 (es) 2007-07-01
AU7289996A (en) 1997-05-07
EP0865295B1 (de) 2007-01-03
CA2243948C (en) 2008-07-08
CA2243948A1 (en) 1997-04-24
EP0865295A1 (de) 1998-09-23
DE69636814T2 (de) 2007-10-04

Similar Documents

Publication Publication Date Title
RU94031102A (ru) Сульфамиды в качестве антагонистов эндотелина и способ лечения соответствующих заболеваний
DE69008010D1 (de) Sauerstoffdelignifizierung und enzymatische Behandlung.
AU6760987A (en) Method of treating alzheimer's disease
ATE168268T1 (de) Behandlung von menschlichen retrovirus- infektionen mit 2',3'-dideoxyinosin
BR9306040A (pt) Tratamento e profilaxia de doenças provocadas por parasitos ou bactérias
DE3280344D1 (de) Verwendung von retinoiden und minoxidil (2,4-diamino-6-piperidino-pyrimidine-3-oxid) zur verbesserung des wachstums von menschlichem kopfhaar und zur behandlung bestimmter typen von alopecia.
ATE78399T1 (de) Verwendung von buspiron zur verbesserung des kurzzeitgedaechtnisses.
DE68907423D1 (de) Behandlung der akne.
IT1275556B (it) Procedimento ed impianto per la disidratazione di foraggio, particolarmente per la disidratazione dell'erba medica
DE59609208D1 (de) Herstellung von Mischkristallen und festen Lösungen von 1,4-Diketopyrrolopyrrolen
DE3888994D1 (de) Behandlung von androgener Alopecia mit 17-beta-n-mono-substituierten-carbamoyl-4-aza-5-alpha-androst-1-en-3-onen.
ATE221763T1 (de) Die verwendung von glyceryltriacetat zur behandlung von onychomykosen
DE68903840D1 (de) Verwendung von 3'-azido-deoxythymidin zur herstellung eines arzneimittels zur behandlung von humanen brustcarzinomen.
DE69636814D1 (de) Verwendung des menschlichen choriongonadotropins in der behandlung von kaposi's-sarcoma
DE68911776D1 (de) Konjugierte Oxybutenolide zur Behandlung von Ulcera.
BG50159A3 (en) Method for preparing derivatives of piranobenzadiasole
DE69007486D1 (de) Verwendung von calciumantagonisten für die behandlung von narben.
ATE100826T1 (de) Behandlung von celluloseblaettern.
DE68923219D1 (de) Behandlung von Abfällen.
DE3856329D1 (de) Verwendung von Ethisterone zur topischen Behandlung von Akne oder androgenetischer Alopezie
DE68905657D1 (de) Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.
GB2216793B (en) Treatment or prophylaxis of acne, dandruff or related conditions
ATE83480T1 (de) Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen.
DE3751510D1 (de) Düse zur Behandlung von Fäden.
DE69016693D1 (de) Züchtung von transformierten Mikroorganismen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: LABORATOIRES SERONO S.A., COINSINS, VAUD, CH

8328 Change in the person/name/address of the agent

Representative=s name: GRAF VON STOSCH PATENTANWALTSGESELLSCHAFT MBH, 805

8339 Ceased/non-payment of the annual fee